Evidence map›Paper›PMID 35835738›Full record

ArticleNature communications2022

Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.

Fauzia K Musasia, Irene N Nkumama, Roland Frank, Victor Kipkemboi, Martin Schneider, Kennedy Mwai, Dennis O Odera, Micha Rosenkranz, Kristin Fürle, Domitila Kimani and 7 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02739763 (Controlled Human Malaria Infection), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02739763 phase1unknown statusnot on this map

Controlled Human Malaria Infection (CHMI) to Assess Human Immunity to P. Falciparum Using Sporozoites Administered by Direct Venous Inoculation

TypeinterventionalSponsorUniversity of OxfordRan2016 to 2020Enrolled200ConditionsMalariaArmsPlasmodium falciparum sporozoite (PfSPZ)
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Effect of periostin (OSF-2) on phagocytosis ofFrontiers in microbiology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Characterization of a novelFrontiers in immunology · 2023
    Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 5 countries.

Fauzia K MusasiaCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Irene N NkumamaCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Roland FrankCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Victor KipkemboiCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Martin SchneiderGenomics and Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany.
Kennedy MwaiCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID 0000-0002-7757-7516
Dennis O OderaCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Micha RosenkranzCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Kristin FürleCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Domitila KimaniCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
James TujuCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Patricia NjugunaCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Mainga HamalubaCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID 0000-0002-0266-1414
Melissa C KapuluCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Hedda WardemannDivision of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.ORCID 0000-0003-3921-5933
CHMI-SIKA Study Team
Faith H A OsierCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany. f.osier@imperial.ac.uk.ORCID 0000-0001-7133-5375
Kenya Medical Research Institute · KEHeidelberg University · DEGerman Cancer Research Center · DEPwani University · KESanaria · USUniversity of Cambridge · GBStrathmore University · KEUniversity of the Witwatersrand · ZA

Funding

Department of Health 16/136/33EPA EP-C-15-003Wellcome TrustWellcome Trust 107499Wellcome Trust 107754/Z/15/ZWellcome Trust 107769/Z/10/Z
6 · The paper itself

Abstract

Ring-infected erythrocytes are the predominant asexual stage in the peripheral circulation but are rarely investigated in the context of acquired immunity against Plasmodium falciparum malaria. Here we compare antibody-dependent phagocytosis of ring-infected parasite cultures in samples from a controlled human malaria infection (CHMI) study (NCT02739763). Protected volunteers did not develop clinical symptoms, maintained parasitaemia below a predefined threshold of 500 parasites/μl and were not treated until the end of the study. Antibody-dependent phagocytosis of both ring-infected and uninfected erythrocytes from parasite cultures was strongly correlated with protection. A surface proteomic analysis revealed the presence of merozoite proteins including erythrocyte binding antigen-175 and -140 on ring-infected and uninfected erythrocytes, providing an additional antibody-mediated protective mechanism for their activity beyond invasion-inhibition. Competition phagocytosis assays support the hypothesis that merozoite antigens are the key mediators of this functional activity. Targeting ring-stage parasites may contribute to the control of parasitaemia and prevention of clinical malaria.

Indexed as

MalariaMalaria, FalciparumParasitesAnimalsAntibodies, ProtozoanAntigens, ProtozoanErythrocytesHumansMerozoitesParasitemiaPhagocytosisPlasmodium falciparumProteomicsAntibodies, ProtozoanAntigens, Protozoan

Identifiers

PMID35835738
PMCPMC9281573
OpenAlexW4285388734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.